30 Apr, 2021 Penalizing Resale Price Maintenance in China’s Pharmaceutical Industry By Nathan Bush Ray Xu Della Ding On April 15, 2021, the State Administration of Market Regulation (SAMR) fined Yangtze River Pharmaceutical Group (“Yangtze River”), a...
30 Apr, 2021 S 415, narrowing the scope of new chemical entities, is now law: implications for innovator companies By Ellen Scordino Lisa Haile Christian Chessman Jamie Gregorian +1 more... Show less President Joe Biden has signed into law S 415, amending the Federal Food, Drug, and Cosmetic Act to address the scope of what constitutes...
22 Apr, 2021 China’s Revised Regulations on Medical Devices: Good News for Industry Stakeholders? By Horace Lam William Fisher Ting Xiao On 9 February 2021, the PRC State Council issued the revised PRC Regulations on the Supervision and Administration of Medical Devices...
19 Apr, 2021 The Digital Green Certificate: health providers as trusted attribute providers within the EU-ID framework? By Florian De Rouck Kristof De Vulder The European Commission is currently working out a Digital Green Certificate mechanism with the eHealth Network. The setting-up of this...
13 Apr, 2021 TGA's Consultation on Managing Medicine Shortages By Joanne Lim The Australian Therapeutic Goods Administration (TGA) is currently conducting a public consultation on proposals to help prevent,...
12 Apr, 2021 The New Romanian Food Supplements Law - what it means for consumers and for the healthcare business By Amalia Musat A complex piece of legislation governing the regime of the food supplements was published with the Official Gazette of Romania on 1 April...
09 Apr, 2021 Life sciences strategies for functional claiming after Amgen By Christian Chessman Kristin Beale Stuart E. Pollack
07 Apr, 2021 Patent eligibility in bioinformatics: Federal Circuit affirms rejection of computerized haplotype phasing claims By John McDermott Susan Krumplitsch In a pair of opinions issued in March, the Federal Circuit affirmed two Patent Trial and Appeal Board determinations that...
07 Apr, 2021 Financial Services in the Cannabis Industry: A Compliance Guide By Christopher Gismondi Wendy Michael Jeffrey Hare Interest in cannabis is at an all-time high. In 2020, Americans bought $18.3 billion in cannabis products, a $7.6 billion increase from...